explore -WSS

explore

author：Wikipedia 2025-10-02 13:37:47 - browse：27587

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： 5 shark bites reported on Long Island as officials deploy surveillance drones

leisure time

WSS

Why scientists need input from humanists on sensitive research

WuXi out of biotech trade group, U.S. and China relations to blame

Amid AI frenzy, a top HHS official's quest to create safeguards

RaDonda Vaught links Vanderbilt hospital issues to patient death

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

knowledge

explore

focus

At least 13 dead in Texas as scorching temps continue

China dismisses criticism of top diplomat's comments appearing to push for race

Sports medicine is finally prioritizing gender equality

WuXi out of biotech trade group, U.S. and China relations to blame

Wildfire smoke exposes gaps in outdoor worker protections

First U.S. drug developed to treat liver disease MASH is approved

Anesthesiologist group: stop taking Ozempic before surgery

How to save health care price transparency rules

Peter Hotez and the public health issue of online harassment

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

focus

Change Healthcare outage fallout shows need for new oversight

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

First U.S. drug developed to treat liver disease MASH is approved

HHS secretary Becerra pressed on Change HealthCare cyberattack

Amid AI frenzy, a top HHS official's quest to create safeguards

focus

leisure time

focus

entertainment